![Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ... Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00544/asset/images/medium/jm-2016-005448_0010.gif)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...
![New Approaches to Difficult Drug Targets: The Phosphatase Story - John S. Lazo, Kelley E. McQueeney, Elizabeth R. Sharlow, 2017 New Approaches to Difficult Drug Targets: The Phosphatase Story - John S. Lazo, Kelley E. McQueeney, Elizabeth R. Sharlow, 2017](https://journals.sagepub.com/cms/10.1177/2472555217721142/asset/images/large/10.1177_2472555217721142-fig1.jpeg)
New Approaches to Difficult Drug Targets: The Phosphatase Story - John S. Lazo, Kelley E. McQueeney, Elizabeth R. Sharlow, 2017
![Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ... Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00544/asset/images/medium/jm-2016-005448_0002.gif)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...
![64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression | Bioconjugate Chemistry 64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression | Bioconjugate Chemistry](https://pubs.acs.org/cms/10.1021/bcches.2007.18.issue-3/asset/largecover.jpg)
64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor Expression | Bioconjugate Chemistry
![Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00249/asset/images/large/jm0c00249_0005.jpeg)